セッション情報

FACO Poster Session

第56回・2018年・横浜
FACO Poster Session
FACO Poster Session 3
FACO Poster Session 3
開催回
第56回・2018年・横浜

演題取り下げ

演題番号 : FP3-1

演題取り下げ

演題取り下げ

演題番号 : FP3-2

演題取り下げ

演題取り下げ

演題番号 : FP3-3

演題取り下げ

Combined promoter methylation detection of free-circulating tumor-associated DNA in colorectal cancer

演題番号 : FP3-4

Speaker)Weiwei Tang:1,2、Hanxiang An:1、Dan Zhou:3、Lilin Chen:1、Mingquan Cai:1、Feng Ye:1、Yun Zhang:4,5

1:Department of Medical Oncology, Xiamen Cancer Hospital, The First Affiliated Hospital of Xiamen University, China、2:Department of Oncology, Fujian Medical University, China、3:Xiang'an Hospital of Xiamen University, China、4:Key Laboratory of Design and Assembly of Functional Nanostructures, Fujian Provincial Key Laboratory of Nanomaterials, Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences, China、5:Xiamen Institute of Rare Earth Materials, Chinese Academy of Sciences, China

Combined promoter methylation detection of free-circulating tumor-associated DNA in colorectal cancer

演題取り下げ

演題番号 : FP3-5

演題取り下げ

演題取り下げ

演題番号 : FP3-6

演題取り下げ

演題取り下げ

演題番号 : FP3-7

演題取り下げ

演題取り下げ

演題番号 : FP3-8

演題取り下げ

COX-2 expression in circulating tumor cells for prognosis prediction in patients with colorectal cancer

演題番号 : FP3-9

Speaker)Jinlin Cai:1、Liang Huang:1、Pinzhu Huang:1、Meijin Huang:1、Liang Kang:1、Jianping Wang:1

1:The Sixth Affiliated Hospital, Department of Colorectal Surgery, Sun Yat-sen University, China

COX-2 expression in circulating tumor cells for prognosis prediction in patients with colorectal cancer

演題取り下げ

演題番号 : FP3-10

演題取り下げ

演題取り下げ

演題番号 : FP3-11

演題取り下げ

演題取り下げ

演題番号 : FP3-12

演題取り下げ

Adjuvant chemotherapy improves prognosis in resectable stage IV colorectal cancer with regional nodal metastasis: A propensity score-based analysis

演題番号 : FP3-13

Speaker)Hiroaki Nozawa:1、Kazushige Kawai:1、Keisuke Hata:1、Toshiaki Tanaka:1、Takeshi Nishikawa:1、Kazuhito Sasaki:1、Manabu Kaneko:1、Shigenobu Emoto:1、Yasutaka Shuno:1、Masaya Hiyoshi:1、Kiyoshi Hasegawa:2、Jun Nakajima:3

1:Department of Surgical Oncology, The University of Tokyo, Japan、2:Department of Hepatobiliary and Pancreatic Surgery, The University of Tokyo, Japan、3:Department of Thoracic Surgery, The University of Tokyo, Japan

Adjuvant chemotherapy improves prognosis in resectable stage IV colorectal cancer with regional nodal metastasis: A propensity score-based analysis

Clinical characteristics and prognostic factors of primary extranodal classical Hodgkin lymphoma: A retrospective study of 27 cases

演題番号 : FP3-14

Speaker)Mingzi Yang:1、Meng Wu:1、Lingyan Ping:1、Weiping Liu:1、Liya A:1、Yanfei Liu:1、Reyizha Nuersulitan:1、Yuqin Song:1、Jun Zhu:1

1:Department of Lymphoma, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, China

Clinical characteristics and prognostic factors of primary extranodal classical Hodgkin lymphoma: A retrospective study of 27 cases

Clinicopathological features and prognosis of 387 cases with classical Hodgkin lymphoma from China

演題番号 : FP3-15

Speaker)Mingzi Yang:1、Meng Wu:1、Lingyan Ping:1、Weiping Liu:1、Liya A:1、Yanfei Liu:1、Reyizha Nuersulitan:1、Yuqin Song:1、Jun Zhu:1

1:Department of Lymphoma, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, China

Clinicopathological features and prognosis of 387 cases with classical Hodgkin lymphoma from China

Anemia has a negative impact on the outcome of patients with Hodgkin lymphoma

演題番号 : FP3-16

Speaker)Weiping Liu:1、Mingzi Yang:1、Meng Wu:1、Lingyan Ping:1、Xiaopei Wang:1、Yuqin Song:1、Jun Zhu:1

1:Department of Lymphoma, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, China

Anemia has a negative impact on the outcome of patients with Hodgkin lymphoma

Hepatitis B virus infection status is not associated with poor prognosis in classical Hodgkin lymphoma patients

演題番号 : FP3-17

Speaker)Weiping Liu:1、Mingzi Yang:1、Meng Wu:1、Lingyan Ping:1、Xiaopei Wang:1、Yuqin Song:1、Jun Zhu:1

1:Department of Lymphoma, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, China

Hepatitis B virus infection status is not associated with poor prognosis in classical Hodgkin lymphoma patients

A clinical study on CD33-directed chimeric antigen receptor modified NK cells in patient with refractory or relapsed acute myeloid leukemia

演題番号 : FP3-18

Speaker)Leiming Xia:1、Yi Wang:1、Liu Liu:1、Tan Li:1、Bin Li:1、Qiao Li:2、Lin Yang:3、Yangyi Bao:1

1:Department of Hematology, The Third Affiliated Hospital of Anhui Medical University, China、2:Comprehensive Cancer Center, University of Michigan, USA、3:Persongen Biomedicine (Suzhou) Co., Ltd., China

A clinical study on CD33-directed chimeric antigen receptor modified NK cells in patient with refractory or relapsed acute myeloid leukemia

Impact of molecular response of Nilotinib for BCR/ABL1 transcripts > 10% with Imatinib 3 and/or 6 months by Sokal risk in chronic phase chronic myelogenous leukemia

演題番号 : FP3-19

Speaker)Zhijian Cao:1、Jun Ma:1

1:Hematology, Harbin Institute of Hematology & Oncology, China

Impact of molecular response of Nilotinib for BCR/ABL1 transcripts > 10% with Imatinib 3 and/or 6 months by Sokal risk in chronic phase chronic myelogenous leukemia

PI3K/AKT activation induce Ibrutinib resistance in chronic lymphocytic leukemia

演題番号 : FP3-20

Speaker)Li Yue:1,2、Kapoor Isha:2、Zhu Huayuan:1、Hill Brian:3、Li Jianyong:1、Xu Wei:1、Almasan Alexandru:2

1:Jiangsu Province Hospital, the First Affiliated Hospital of Nanjing Medical University, China、2:Department of Cancer Biology, Cleveland Clinic, Lerner Research Institute, USA、3:Department of Hematology and Oncology, Cleveland Clinic, Taussig Cancer Center, China

PI3K/AKT activation induce Ibrutinib resistance in chronic lymphocytic leukemia

Lymphoma patients with lower CD34+ cells yields can benefit from autologous hematopoietic stem cell transplantation

演題番号 : FP3-21

Speaker)Weiping Liu:1、Xiaopei Wang:1、Meng Wu:1、Yuqin Song:1、Jun Zhu:1

1:Department of Lymphoma, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, China

Lymphoma patients with lower CD34+ cells yields can benefit from autologous hematopoietic stem cell transplantation

Efficacy and safety of allogeneic stem-cell transplantation as salvage therapy for peripheral T-cell lymphomas

演題番号 : FP3-22

Speaker)Ying Zhou:1、Li Yu:2

1:Oncology, Department of Oncology, Nantong Tumor Hospital, China、2:Hematology, Department of Hematology, Chinese PLA General Hospital, China

Efficacy and safety of allogeneic stem-cell transplantation as salvage therapy for peripheral T-cell lymphomas

T-cell receptor signaling pathway, a novel candidate therapeutic target for the treatment of AITL.

演題番号 : FP3-23

Speaker)Yalu Liu:1、Ning Ding:1、Yuqin Song:1、Xiaogan Wang:1、Lijuan Deng:1、Lingyan Ping:1、Yunfei Shi:2、Wen Zheng:1、Ningjing Lin:1、Xiaopei Wang:1、Meifeng Tu:1,2、Yan Xie:1、Zhengying Pan:3、Xi Wang:4、Jun Zhu:1

1:Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Lymphoma, Peking University Cancer Hospital & Institute, China、2:Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Pathology, Peking University Cancer Hospital & Institute, China、3:Key Laboratory of Chemical Genomics, Department of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School, China、4:Laboratory of Immunology, Department of Immunology, Capital Medical University, China

T-cell receptor signaling pathway, a novel candidate therapeutic target for the treatment of AITL.

Combination of enzastaurin and ibrutinib synergistically induces anti-tumor effects in diffuse large B cell lymphoma

演題番号 : FP3-24

Speaker)Yizi He:1、Jiao Li:1、Hui Yu:1、Ning Ding:1、Xiaogan Wang:1、Yuqin Song:1、Jun Zhu:1

1:Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Lymphoma, Peking University Cancer Hospital & Institute, China

Combination of enzastaurin and ibrutinib synergistically induces anti-tumor effects in diffuse large B cell lymphoma

A real world study of efficacy and safety with apatinib therapy in advanced neuroendocrine carcinoma patients

演題番号 : FP3-25

Speaker)Chao Chen:1、Xiufeng Liu:1、Xinlei Gong:1、Chenglong Han:1、Xianwen Luo:1

1:Department of Medical Oncology of PLA Cancer Center, Bayi Hospital Affiliated Nanjing University of Chinese Medicine, China

A real world study of efficacy and safety with apatinib therapy in advanced neuroendocrine carcinoma patients

A real world study of efficacy and safety with apatinib therapy inadvanced sarcoma patients

演題番号 : FP3-26

Speaker)Chao Chen:1、Xiufeng Liu:1、Xinlei Gong:1、Ying Cheng:1、Chenglong Han:1

1:Department of Medical Oncology of PLA Cancer Center, Bayi Hospital Affiliated Nanjing University of Chinese Medicine, China

A real world study of efficacy and safety with apatinib therapy inadvanced sarcoma patients

The role of random cervical biopsies in addition to colposcopy-directed biopsies in detection of CIN2+

演題番号 : FP3-27

Speaker)Nutthaporn Chandeying:1、Atittaya Vallapapan:1

1:Department of Obstetrics and Gynecology, Faculty of Medicine Vajira Hospital, Navamindradhiraj University, Thailand

The role of random cervical biopsies in addition to colposcopy-directed biopsies in detection of CIN2+

演題取り下げ

演題番号 : FP3-28

演題取り下げ

演題取り下げ

演題番号 : FP3-29

演題取り下げ

演題取り下げ

演題番号 : FP3-30

演題取り下げ

演題取り下げ

演題番号 : FP3-31

演題取り下げ

Universal screening for Lynch Syndrome in a large consecutive cohort of Chinese colorectal cancer patients: High prevalence and unique molecular features

演題番号 : FP3-32

Speaker)Wu Jiang:1、Peirong Ding:1、Muyan Cai:2、Shiyong Li:3、Jinxin Bei:4、Fang Wang:5、Jibin Li:6、Zhizhong Pan:1

1:Department of Colorectal Surgery, Sun Yat-sen University Cancer Center, China、2:Department of Pathology, Sun Yat-sen University Cancer Center, China、3:BGI-Guangzhou Medical Laboratory, BGI-Shenzhen, China、4:Department of Experimental Research, Sun Yat-sen University Cancer Center, China、5:Department of Molecular Diagnostics, Sun Yat-sen University Cancer Center, China、6:Department of Clinical Research, Sun Yat-Sen University Cancer Center, China

Universal screening for Lynch Syndrome in a large consecutive cohort of Chinese colorectal cancer patients: High prevalence and unique molecular features

演題取り下げ

演題番号 : FP3-33

演題取り下げ

Effect of a combined treatment with Enteral nutritional powder and megestrol acetate for malnourished cancer patients

演題番号 : FP3-34

Speaker)Jun B. Duan:1、Jun Bai:1、Xi Wang:1、Li He:1、Hua J. Wang:2、Song Y. Pu:2、Yu Zhang:3、Bin Song:2

1:Medical Oncology, Sha'anxi Provencial People's Hospital, China、2:General Surgery, Sha'anxi Provencial People's Hospital, China、3:Heppatobiliary Surgery, Sha'anxi Provencial People's Hospital, China

Effect of a combined treatment with Enteral nutritional powder and megestrol acetate for malnourished cancer patients